A Natural History Study of the Gangliosidoses
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT00668187
- Status
- Recruiting
Conditions
- GM1 Gangliosidosis
- GM2 Gangliosidosis
- Late Onset Tay-Sachs Disease
- Sandhoff Disease
- Tay-Sachs Disease
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
Hypothesis: To characterize and describe disease progression and heterogeneity of the gangliosidosis diseases. This research study seeks to develop a quantitative method to delineate disease progression for the gangliosidosis diseases (Tay-Sachs disease, Sandhoff disease, and GM1 gangliosidosis) in order to better understand the natural history and heterogeneity of these diseases. Such a quantitative method will also be essential for evaluating any treatments that may become available in the future, such as gene therapy. The data from this study will be necessary to provide end-points for future therapies, guide medical decisions about treatment, provide objective measurement of treatment outcomes, and accurately inform parents regarding potential outcomes.
Key Dates
- Start date
- Dec 31, 2010
- Status verified
- Mar 2026
- Primary completion
- Mar 1, 2027
- Completion
- Mar 1, 2027
Study Design
- Enrollment
- 52 participants (estimated)
Arms
- Arm: Gangliosidosis Diseases Study PopulationThis study observes one cohort: 42 infantile or juvenile Tay-Sachs disease, Sandhoff disease, or GM1 gangliosidosis affected subjects; and 10 late-onset gangliosidosis disease affected subjects.
Primary Outcome Measure
Change in Child Developmental Status as Assessed by Neuropsychological Tests [ Time Frame: Upon enrollment; then at 12, 24, 36, 48 and 60 months ]
Central Contacts
- Jeanine R. Jarnes, PharmD612-626-5131
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota - Pediatric Genetics and Metabolism | Minneapolis | Minnesota | 55455 | Jeanine R. Jarnes, PharmD (PRINCIPAL_INVESTIGATOR) Chester B. Whitley, MD, PhD (SUB_INVESTIGATOR) |
Find similar trials in Minneapolis, MN
Related Studies
- The Myelin Disorders Biorepository ProjectRecruiting · Children's Hospital of Philadelphia · Los Angeles, California
- A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 GangliosidosisPHASE3 · Recruiting · Azafaros A.G. · Oakland, California
- UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like CellsPHASE1 · Recruiting · Joanne Kurtzberg, MD · Durham, North Carolina
- Longitudinal Study of Neurodegenerative DisordersRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania